NAVIDEA BIOPHARMACEUTICALS, INC. Uncategorized Contracts & Agreements
53 Contracts & Agreements
- Offer Letter between Navidea Biopharmaceuticals, Inc. and Craig Dais dated July 26, 2023 (Filed With SEC on July 28, 2023)
- Form of Dealer-Manager Agreement (Filed With SEC on August 2, 2022)
- Amended and Restated Equity Commitment Letter, dated August 14, 2020, between Mastiff Group LLC and Navidea Biopharmaceuticals, Inc (Filed With SEC on August 14, 2020)
- Description of Securities (Filed With SEC on March 18, 2020)
- Form of Underwriter Warrants of Navidea Biopharmaceuticals, Inc (Filed With SEC on June 17, 2019)
- Agreement dated August 14, 2018, by and among Navidea Biopharmaceuticals, Inc., Macrophage Therapeutics, Inc. and Michael M. Goldberg, M.D (Filed With SEC on November 9, 2018)
- LICENSE-BACK AGREEMENT (Filed With SEC on March 9, 2017)
- DIRECTOR AGREEMENT (Filed With SEC on May 10, 2016)
- DIRECTOR AGREEMENT (Filed With SEC on March 29, 2016)
- DIRECTOR AGREEMENT (Filed With SEC on March 29, 2016)
- AGREEMENT (Filed With SEC on March 18, 2016)
- SUBORDINATIONAGREEMENT (Filed With SEC on May 15, 2015)
- SECURITYAGREEMENT (Filed With SEC on May 15, 2015)
- AGREEMENT BETWEEN NAVIDEA BIOPHARMACEUTICALS, INC. AND ALSERES PHARMACEUTICALS, INC. (Filed With SEC on April 27, 2015)
- NAVIDEA BIOPHARMACEUTICALS, INC. 5600 Blazer Parkway, Suite 200, Dublin, Ohio 43017-7550 Date_of_Grant Employee Address CityState (Filed With SEC on November 10, 2014)
- NAVIDEA BIOPHARMACEUTICALS, INC. 5600 Blazer Parkway, Suite 200Dublin,Ohio 43017-7550 (Filed With SEC on October 15, 2014)
- DIRECTOR AGREEMENT (Filed With SEC on November 19, 2013)
- [Remainder of the pageintentionally left blank.] (Filed With SEC on September 24, 2013)
- AMENDED AND RESTATED PROMISSORYNOTE (TermLoan Facility) (Filed With SEC on June 28, 2013)
- CERTIFICATE OF ELIMINATION OF NAVIDEA BIOPHARMACEUTICALS, INC. (Filed With SEC on June 26, 2013)
- NAVIDEA BIOPHARMACEUTICALS, INC. AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS,VOTING POWERS, PREFERENCES, LIMITATIONS, RESTRICTIONS,AND RELATIVE RIGHTS OF SERIES B CONVERTIBLE... (Filed With SEC on June 26, 2013)
- [123I]NAV5001 Clinical SupplyAgreement THIS AGREEMENT made in duplicate as of this10th day of May, 2013 (Filed With SEC on May 16, 2013)
- NAVIDEA BIOPHARMACEUTICALS, INC. 425 Metro Place North, Suite 450 Dublin, Ohio 43017 December 13, 2012 (Filed With SEC on December 19, 2012)
- SUBLICENSE AGREEMENT By and Between ALSERES PHARMACEUTICALS, INC. and NAVIDEA BIOPHPARMACEUTICALS, INC. (Filed With SEC on August 6, 2012)
- OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and NEOPROBE CORPORATION DATE: 9 DECEMBER 2011 (Filed With SEC on April 11, 2012)
- OUT-LICENCE AGREEMENT by and between ASTRAZENECA AB and NEOPROBE CORPORATION DATE: 9 DECEMBER 2011 (Filed With SEC on December 15, 2011)
- By:/s/ Mark J. PykettMark J. PykettPresident and Chief Executive Officer (Filed With SEC on August 4, 2011)
- Exhibit 10.1EMPLOYMENT AGREEMENT (Filed With SEC on June 6, 2011)
- Exhibit 10.4 RELOCATION AGREEMENT (Filed With SEC on April 1, 2011)
- SCHEDULEIDENTIFYING MATERIAL DIFFERENCES BETWEEN EMPLOYMENTAGREEMENTS BETWEENNEOPROBE CORPORATION AND THEINDIVIDUALS LISTED BELOW (Filed With SEC on December 27, 2010)
- EMPLOYMENTAGREEMENT (Filed With SEC on December 27, 2010)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on November 12, 2010)
- Rodman& Renshaw, LLC 1251 Avenue of the Americas, 20th Floor,New York, NY 10020 Tel ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC (Filed With SEC on November 12, 2010)
- MANUFACTURE AND SUPPLYAGREEMENT (Filed With SEC on August 10, 2010)
- SECURITIESEXCHANGE AGREEMENT (Filed With SEC on June 28, 2010)
- SECURITIESEXCHANGE AGREEMENT (Filed With SEC on June 28, 2010)
- EMPLOYMENTAGREEMENT (Filed With SEC on February 26, 2010)
- EMPLOYMENTAGREEMENT (Filed With SEC on January 6, 2010)
- NEOPROBECORPORATION Amendedand Restated 10% Series B Senior Secured Convertible PromissoryNote dueDecember 26, 2011 (Filed With SEC on July 29, 2009)
- NEOPROBECORPORATION Amendedand Restated 10% Series A Senior Secured Convertible PromissoryNote dueDecember 26, 2011 (Filed With SEC on July 29, 2009)
